Collagen for knee pain: study results
What studies of collagen peptides found for knee pain in active adults and people with osteoarthritis.
Key points
- In active people aged 18–30 with knee pain during exercise, specific peptides produced a small additional reduction in pain over 12 weeks versus placebo, about 6 points on a 100-point scale. A small change specifically in exercise-related pain may be expected in this group. [1] See the evidence 1
- In active adults aged 50–75, another 12-week study found no clear hydrolysate advantage for knee pain. Results in younger participants should not automatically be extrapolated to this group. [2] [1] See the evidence 1 2
- In knee osteoarthritis, pain decreased more over six months with a blend of collagen peptides and calcium ascorbate than with placebo. The effect applies to the blend; collagen’s separate contribution was not established. [3] See the evidence 1
Practical guide
Check the conclusions and whether they apply to your situation.
Studies of collagen for knee pain included different age groups, formulations and causes of pain. Results differed.
Key points
Why these conclusions
Knee pain: study results
Active adults aged 18–30 with exercise-related knee pain without diagnosed disease took 5 g specific hydrolysed type I peptides daily or placebo for 12 weeks. Exercise-related pain decreased slightly more in the peptide group: mean additional difference in changes about 6.3 mm on a 100 mm scale. Confidence is low, 2 out of 4. [1]
In a study of active adults aged 50–75 with knee pain, 10 g bovine hide hydrolysate Peptan B2000 daily was compared with maltodextrin for 12 weeks. No clear advantage for pain was found; confidence is low, 2 out of 4. [2]
In a study of adults with knee osteoarthritis, a blend of 10 g peptides and 80 mg calcium ascorbate reduced pain more over six months than placebo without active vitamin C. Both components changed together, so the result applies to the blend; confidence is very low, 1 out of 4. [3]
Over six months, pain decreased more with a blend of 10 g peptides and 80 mg calcium ascorbate than placebo without active vitamin C. The result applies to the blend.
| Parameter | Data |
|---|---|
| Result | Over six months, pain decreased more with a blend of 10 g peptides and 80 mg calcium ascorbate than placebo without active vitamin C. The result applies to the blend. |
| Participants | 120 adults with knee osteoarthritis, 60 per group |
| Form | 10 g collagen peptides plus 80 mg calcium ascorbate |
| Dose | 10 g collagen peptides plus 80 mg calcium ascorbate |
| Dose basis | 10 g collagen peptides plus 80 mg calcium ascorbate |
| Comparator | Placebo without active vitamin C |
| Duration | 6 months |
| Confidence | 1/4: Precision: No confirmed CI for the contrast. Consistency: No reason for separate downgrading; no additional reduction on this basis. Applicability: Vitamin C changes together with peptides. Publication bias: No specific data for separate downgrading; no additional reduction on this basis. Methods: At baseline, analgesics were used by 28.3% in the blend group and 71.7% in placebo; vitamin C changed together with peptides. |
| Evidence base | 1 trial |
| Sources | [3] |
Over 12 weeks, exercise-related pain decreased slightly more on specific type I peptides than placebo: mean difference in changes about 6.3 mm on a 0–100 mm scale.
| Parameter | Data |
|---|---|
| Result | Over 12 weeks, exercise-related pain decreased slightly more on specific type I peptides than placebo: mean difference in changes about 6.3 mm on a 0–100 mm scale. |
| Participants | 180 active men and women aged 18–30 who completed the study, with exercise-related knee pain without diagnosed disease |
| Form | specific hydrolysed type I collagen peptides |
| Dose | 5 g/day |
| Dose basis | 5 g/day |
| Comparator | placebo |
| Duration | 12 weeks |
| Confidence | 2/4: Precision: Small effect or non-significant result, with no extracted CI for the contrast. Consistency: No reason for separate downgrading; no additional reduction on this basis. Applicability: Measurement directly addresses the stated narrow PICO; no additional reduction on this basis. Publication bias: No specific data for separate downgrading; no additional reduction on this basis. Methods: Completer data and self-report, limited attrition reporting. |
| Evidence base | 1 trial |
| Sources | [1] |
Over 12 weeks no clear advantage of peptides over placebo for knee pain was found.
| Parameter | Data |
|---|---|
| Result | Over 12 weeks no clear advantage of peptides over placebo for knee pain was found. |
| Participants | 200 active adults aged 50–75 with self-reported knee pain were randomised; 167 analysed, median age 63 |
| Form | bovine hide hydrolysate Peptan B2000 |
| Dose | 10 g/day |
| Dose basis | 10 g/day |
| Comparator | 10 g maltodextrin daily |
| Duration | 12 weeks |
| Confidence | 2/4: Precision: Mean changes −1.6±2.4 and −1.9±2.6, p=0.42; CI for the difference not presented. Consistency: No reason for separate downgrading; no additional reduction on this basis. Applicability: Measurement directly addresses the stated narrow PICO; no additional reduction on this basis. Publication bias: No specific data for separate downgrading; no additional reduction on this basis. Methods: 200 randomised, 167 analysed; median group ages differed (65 and 61 years). |
| Evidence base | 1 trial |
| Sources | [2] |
Sources
- The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial. https://pubmed.ncbi.nlm.nih.gov/33562729/
- Effectiveness of collagen supplementation on pain scores in healthy individuals with self-reported knee pain: a randomized controlled trial. https://pubmed.ncbi.nlm.nih.gov/31990581/
- Oral administration of hydrolyzed collagen alleviates pain and enhances functionality in knee osteoarthritis: Results from a randomized, double-blind, placebo-controlled study. https://pmc.ncbi.nlm.nih.gov/articles/PMC11745964/
Methodology: Subpages evidence-led supplement pipeline v1